Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Transcriptome profiling of different celltype of cells (Progenitor cells/Enteroendocrine cells/Enteroblast cells) and Sox100B depleted/overexpressed progenitor cells in Drosophila intestine

ABSTRACT: Purpose: 1)To compare transcriptome profiling (RNA-seq) of intestinal progenitor cells in Drosophila wild type and Sox100B depleted/overexpressed midgut. 2)To identify cell-type enriched genes and early-transcribed EC/EE genes by comparing transcriptome profiling (RNA-seq) of different celltype of cells Results: Each sequencing experiment generated more than 20 million raw reads, and 92.5% was uniquely mapped for each experiment. 2310 genes of the transcripts showed significantly differential expression between the WT and Sox100B-OE progenitor cells, and 2181 genes of the transcripts showed significantly differential expression between the WT and Sox100B-IR progenitor cells, with a fold change ≥2.0 and p value <0.05. Genes that showed low level in progenitor cells while significantly higher level in terminally differentiated EC/EE cells were identified as early transcribed EC/EE genes. 169 genes were identified as early-transcribed EC genes and 452 genes were identified as early-transcribed EE genes.

ORGANISM(S): Drosophila melanogaster

PROVIDER: GSE130303 | GEO | 2020/05/18

REPOSITORIES: GEO

ACCESS DATA

Json Xml

Similar Datasets

Chemoradiation and Endothelial Progenitor Cells in Colorectal Cancer

Project description:Colorectal cancer (CRC) is one of the common malignancies worldwide, accounting for a significant percentage of cancer mortality. Concurrent chemoradiation (CCRT) is now a standard treatment for unresectable malignancies of anorectum. To improve quality of life, CCRT is also commonly applied in treatment of lower rectal and anal canal cancer to preserve anal sphincter function. The most commonly used chemotherapeutic drugs combined with radiation as radiosensitizers is 5-fluorouracil (5-FU). Circulating endothelial progenitor cells (EPC), which contribute to the tumor vessel formation, reflect the response to chemotherapy both in animal model and clinical trial. Thus, circulating EPC can be used as a marker for optimizing and monitoring the anti-angiogenesis therapy including angiogenesis inhibitors and chemotherapy. Whether circulating EPC can be served as a marker of CCRT efficacy or not remains undetermined. Since CCRT is now a standard treatment of locally advanced and high-risk CRC, the development of a surrogate marker for monitoring CCRT response and optimize treatment intensity is very important. In this grant we intent to monitor the levels of circulating EPC in locally advanced and high-risk CRC patients before, during and after CCRT. To further characterize the changes in function and biology of EPC caused by CCRT, a syngeneic animal model will be also used to evaluate the clonogenecity and specific gene expression of EPC in tumor-bearing mice receiving CCRT.

| 2028928 | ecrin-mdr-crc

Expression of genes in hepatic progenitor-like cells derived from human iPS cells, and cultured progenitor cells

Project description:Expression of genes in hepatic progenitor-like cells derived from human iPS cells, and cultured progenitor cells

| PRJNA407893 | ENA

Induced muscle progenitor cells

Project description:Induced muscle progenitor cells

| PRJNA716685 | ENA

Induced muscle progenitor cells

Project description:Induced muscle progenitor cells

| PRJNA648431 | ENA

Ageing-associated proteome and acetylome of hematopoietic progenitor cells

Project description:Ageing-associated proteome and acetylome of hematopoietic progenitor cells

2020-09-24 | PXD021651 | iProX

Neurog3 gene dosage effect on the differentiaiton of intestinal enteroendocrine progenitors

Project description:Analysis of FACS-sorted intestinal Neurog3+/+ and Neurog3+/- cells from Neurog3 fluorencent reporter mice carrying two-(+/+) or one- (+/-) Neurog3 alleles. In the intestine, Neurog3 is an enteroendocrine (EE) lineage determinating transcription factor that transiently expressed in early EEC progenitors. By comparison the molecular profiles of Neurog3+/+ and Neurog3+/- cells, we hypothesized that Neurog3 gene dosage regulates the allocation of EE progenitor fates towards EEC vs. goblet cells.

2020-08-13 | GSE149203 | GEO

RNA-Regulatory Exosome Complex Confers Erythroid Progenitor Cell Survival and Activity In Vivo

Project description:The RNA exosome complex (EC) confers post-transcriptional regulation by processing and degrading RNAs in a context-dependent manner. Although the EC functions in diverse cell types, its contributions to stem and progenitor cell development have not been widely studied. Previously, we demonstrated that the transcriptional regulator of erythrocyte development GATA1 represses genes encoding EC subunits, and in vitro analyses implicated the EC in maintaining erythroid progenitors. EC loss promoted the transition of progenitors into differentiating erythroblasts. To determine if these mechanisms operate in vivo, we utilized a hematopoietic-specific Vav1-Cre mouse system to conditionally ablate Exosc3, encoding an EC structural subunit with a conserved RNA binding domain. Although Exosc3 fl/fl Cre+ embryos developed normally until E14.5, Exosc3 ablation was embryonic lethal, severely reduced erythro-myeloid progenitor activity and reduced immunophenotypic progenitors. Exosc3 ablation decreased Kit+ hematopoietic progenitors and the level of cell surface c-Kit. RNA-seq analysis of Exosc3-ablated BFU-E revealed elevated transcripts encoding pro-apoptotic factors, including BCL2 family members Bax, Puma and Noxa, the death receptor Fas, and p53 target genes. Exosc3-ablated BFU-E and CFU-E progenitors exhibited increased apoptosis. Although megakaryocyte-erythroid progenitor (MEP) levels were unaltered, they were functionally defective. We propose that the EC controls an ensemble of apoptosis-regulatory RNAs, thereby conferring erythroid progenitor survival and promoting developmental erythropoiesis in vivo.

2022-09-26 | GSE203607 | GEO

Efficient trans-differentiation/ de-differentiation of mature intestinal cells in adult Drosophila midgut by depleting a single transcription factor

Project description:The manipulation of cell identity by reprograming holds immense potential in regenerative medicine, but is often limited by the inefficient acquisition of fully functional cells. This problem can potentially be resolved by better understanding the reprogramming process using in vivo genetic models, which are currently scarce. Here we report that both enterocytes (ECs) and enteroendocrine cells (EEs) in adult Drosophila midgut show a surprising degree of cell plasticity. Depleting the transcription factor Tramtrack in the differentiated ECs can initiate Prospero-mediated cell transdifferentiation leading to EE-like cells. On the other hand, depletion of Prospero in the differentiated EEs leads to the loss of EE-specific transcription programs, allowing cell cycle re-entry or differentiation into ECs. We found that intestinal progenitor cells, ECs, and EEs have a similar chromatin accessibility profile, suggesting that cell plasticity is enabled by pre-existing chromatin accessibility with switchable transcription programs. In a pilot genetic screen using this system, we found that cell lineage confliction and epigenetic memory were potential barriers during the EC-to-EE transdifferentiation. The establishment of this genetically tractable in vivo model should facilitate mechanistic investigation of cell plasticity at the molecular and genetic level.

2024-03-04 | GSE235505 | GEO

LGR6 marks nephron progenitor cells

Project description:LGR6 marks nephron progenitor cells

| PRJNA691957 | ENA